UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 180

of 'Treatment of relapsed or refractory multiple myeloma'

180
TI
Venetoclax Monotherapy for Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Results from a Phase I Study (abstract 488)
AU
Kumar S,Vij R,Kaufman JL,Mikhael J,Facon T
SO
Blood. 2016;
 
AD